Inflation Reduction Act kills incentives for medical innovation

Inflation Reduction Act kills incentives for medical innovation

The Biden administration recently announced the first 10 drugs that will be subject to price controls under Medicare as part of the Inflation Reduction Act. The president celebrated the occasion, saying, “We took on Big Pharma and special interests, overcoming opposition from every Republican in Congress, and the American people won.”

“Won?” The next generation of American patients will not feel like they “won” when they’re stuck waiting even longer for effective treatments — if those treatments ever materialize.

Read the full article in the Detroit News

Share
Share